Tuesday, January 26, 2021
Home Latest Pharma-News

Latest Pharma-News

ViiV Healthcare receives EU Marketing Authorisation for the dolutegravir for HIV

ViiV Healthcare receives EU Marketing Authorisation for the first-ever dispersible-tablet formulation of dolutegravir, Tivicay, a treatment for children living with HIV in...

Roche’s Tecentriq/Avastin combination improves survival in liver cancer

January 12, 2021: Roche will present updated overall survival (OS) data from the Phase III IMbrave150 study evaluating Tecentriq® (atezolizumab) in combination...

Vir Biotechnology and GSK announce NHS-supported AGILE study for COVID-19

January 12, 2021: Vir Biotechnology and GlaxoSmithKline announced an agreement with the U.K.-based AGILE initiative to evaluate VIR-7832 in patients with mild...

Novartis expands Oncology pipeline with in-licensing of tislelizumab from BeiGene

January 11, 2021: "Novartis has signed a strategic collaboration agreement to in-license tislelizumab from BeiGene, Ltd. in major markets outside of China,...

FDA Releases Artificial Intelligence/Machine Learning Action Plan

January 12, 2021: "The U.S. Food and Drug Administration released the agency’s first Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD)...

FDA Conditionally Approves First Oral Tablet to Treat Lymphoma in Dogs

January 11, 2021: "The U.S. Food and Drug Administration conditionally approved Laverdia-CA1 (verdinexor tablets) to treat dogs with lymphoma, a type of...

Promising new treatment strategy for men with drug-resistant prostate cancer

January 12, 2020: "A new experimental drug could offer a promising approach to treating men with advanced prostate cancer which does not...

Biogen to launch pioneering study with Apple watch and iphone

January 11, 2021: "Biogen Inc. announced a new virtual research study, in collaboration with Apple, to investigate the role Apple Watch and iPhone...

Sanofi to acquire Kymab for up to $1.45billion

January 11, 2021: "Sanofi and Kymab, a clinical-stage biopharmaceutical company developing fully human monoclonal antibodies with a focus on immune-mediated diseases and...

Boehringer Ingelheim’s Partnership with Google for Pharma R&D

January 11th, 2021: Boehringer Ingelheim announced today a collaborative agreement with Google Quantum AI (Google), focusing on researching and implementing cutting-edge use...

Roche’s Xofluza approved by the EU for the treatment of influenza

January 11, 2021: "Roche announced that the European Commission (EC) has approved Xofluza® (baloxavir marboxil) for the treatment of uncomplicated influenza in...

FDA Issues Alert Regarding SARS-CoV-2 Viral Mutation to Health Care Providers and Clinical Laboratory Staff

January 08, 2021: "The U.S. Food and Drug Administration is alerting clinical laboratory staff and health care providers that the FDA is...

Most Read

AZ’s Symbicort Turbuhaler approved as an anti-inflammatory reliever in mild asthma

January 26, 2021: "AstraZeneca’s Symbicort Turbuhaler (budesonide/formoterol 160/4.5mcg) has been approved in China as an anti-inflammatory reliever to be taken as-needed in response to...

Calquence approved in Japan for the treatment of relapsed or refractory chronic lymphocytic leukaemia

January 25, 2021: "AstraZeneca’s Calquence (acalabrutinib), a next-generation, selective Bruton’s tyrosine kinase (BTK) inhibitor, has been approved in Japan for the treatment of adult...

What is the process for Submission of Synopsis?

1.1 a. "Prior to submission of a thesis synopsis, a comprehensive assessment of the research work should be carried out by a...

COVAX Announces new agreement, plans for first deliveries

January 22, 2021: COVAX, the global initiative to ensure rapid and equitable access to COVID-19 vaccines for all countries, regardless of income...